MILLENDO THERAPEUTICS

millendo-therapeutics-logo

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

#People #Financial #Website #More

MILLENDO THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2011-01-01

Address:
Ann Arbor, Michigan, United States

Country:
United States

Website Url:
http://www.millendo.com

Total Employee:
11+

Status:
Closed

Contact:
7348459000

Email Addresses:
[email protected]

Total Funding:
116.52 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 GoDaddy DNS COVID-19 Sendgrid Comcast Akamai Hosted KnowBe4



Current Advisors List

marianne-plaunt_image

Marianne Plaunt Vice President, Clinical Operations @ Millendo Therapeutics
Board_member

carol-gallagher_image

Carol Gallagher Board of Directors @ Millendo Therapeutics
Board_member

not_available_image

Martin Phillips Senior Medical Advisor @ Millendo Therapeutics
Advisor

james-topper_image

James Topper Board of Directors @ Millendo Therapeutics
Board_member

Current Employees Featured

gary-hammer_image

Gary Hammer
Gary Hammer Chairman & Co-Founder @ Millendo Therapeutics
Chairman & Co-Founder

Founder


gary-hammer_image

Gary Hammer

julia-c-owens_image

Julia C. Owens

Stock Details


Company's stock symbol is NASDAQ:MLND

Acquisitions List

Date Company Article Price
2018-08-10 OvaScience OvaScience acquired by Millendo Therapeutics N/A
2017-12-20 Amolyt Pharma Amolyt Pharma acquired by Millendo Therapeutics N/A

Investors List

innobio-fund_image

InnoBio Fund

InnoBio Fund investment in Venture Round - Millendo Therapeutics

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Venture Round - Millendo Therapeutics

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Venture Round - Millendo Therapeutics

altitude-life-science-ventures_image

Altitude Life Science Ventures

Altitude Life Science Ventures investment in Venture Round - Millendo Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Venture Round - Millendo Therapeutics

longwood-founders-fund_image

Longwood Fund

Longwood Fund investment in Venture Round - Millendo Therapeutics

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Venture Round - Millendo Therapeutics

adams-street-partners_image

Adams Street Partners

Adams Street Partners investment in Venture Round - Millendo Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - Millendo Therapeutics

adams-street-partners_image

Adams Street Partners

Adams Street Partners investment in Series B - Millendo Therapeutics

Official Site Inspections

http://www.millendo.com

  • Host name: ec2-34-192-255-123.compute-1.amazonaws.com
  • IP address: 34.192.255.123
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Millendo Therapeutics"

Millento

Millento - twoje miejsce na modowe inspiracje. Millento to miejsce tworzone z pasją dla wszystkich kobiet, które cenią sobie styl i jakość. Nasze produkty charakteryzują się dbałością o wykonanie i szczegóły, a każdy element …See details»

Geoff Nichol Appointed to Millendo Therapeutics Board of Directors

Dec 19, 2019 His perspective will have significant impact as we plan our transition to a commercial stage organization.” “Millendo has built a solid foundation with its lead candidate …See details»

Millendo - VentureRadar

Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where... ... Find out more ...See details»

Millendo Therapeutics, Inc. - AnnualReports.com

Millendo Therapeutics is a clinical stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or …See details»

Millendo Therapeutics - Crunchbase Company Profile & Funding

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or …See details»

Millendo plans to go public through OvaScience takeover, in push …

Aug 9, 2018 The new company will focus on Millendo’s rare disease pipeline—earlier this year, the Waltham, Massachusetts-based OvaScience scaled back its R&D efforts into its fertility …See details»

Millendo Therapeutics CEO and Key Executive Team | Craft.co

Millendo Therapeutics's President and Chief Executive Officer is Julia C. Owens. Other executives include Jeffery M. Brinza, Chief Administrative Officer and General Counsel; Pharis …See details»

Millento Reviews - 323 Reviews of Millento.com - Sitejabber

Millento has a rating of 2.8 stars from 323 reviews, indicating that most customers are generally dissatisfied with their purchases. Millento ranks 103rd among Women's Clothing sites. …See details»

Millendo Therapeutics - Craft

Jul 1, 2021 Ann Arbor, MI HQ. United States. 110 Miller Ave Suite 100. Lexington, MA. United States. 420 Bedford St #260. Écully, Auvergne-Rhône-Alpes. France. Espace Européen …See details»

A Biopharma That Had To Pivot Twice To Forge Ahead

Feb 28, 2020 <p>Not many thriving companies experience disappointing clinical trial results, jump into an entirely new therapeutic area, and emerge with investor support and renewed …See details»

Millendo To Merge With Tempest Therapeutics In An All-Stock

Mar 29, 2021 (RTTNews) - Millendo Therapeutics, Inc. (MLND) said Monday that it will merge with the privately-held oncologist company Tempest Therapeutics in an all-stock transaction.See details»

OvaScience and Millendo Therapeutics Announce Merger to

Aug 9, 2018 WALTHAM, Mass. & ANN ARBOR, Mich.--(BUSINESS WIRE)-- OvaScience SM (Nasdaq:OVAS) and privately-held Millendo Therapeutics, Inc., a clinical-stage …See details»

Millendo To Merge With Tempest Therapeutics; Shares Tank

Mar 30, 2021 Millendo Therapeutics has agreed to merge with South San Francisco-based Tempest Therapeutics, a privately-held clinical-stage oncology company, in an all-stock deal. …See details»

Millendo Therapeutics Reports Full Year 2019 Operating and …

Mar 11, 2020 ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc. (Nasdaq: MLND), a late-stage biopharmaceutical company primarily focused on developing novel …See details»

O nas - Millento

Millento to nowy rozdział w świecie mody, stworzony specjalnie dla kobiet, które są odważne, nowoczesne i cenią sobie elegancję. Nasza oferta obejmuje odzież codzienną, eleganckie …See details»

millento.com Reviews: Is this site a scam or legit?

Organization Domains By Proxy, LLC . Owner Registration Private . Address DomainsByProxy.com 100 S. Mill Ave, Suite 1600 . State Arizona . Country UNITED STATES …See details»

Millento - Facebook

Millento. 12,575 likes · 36 talking about this. Radość z zakupów!See details»

Millento (@millento.official) • Instagram photos and videos

535 Followers, 0 Following, 62 Posts - Millento (@millento.official) on Instagram: "millento.com"See details»

Org Chart Creator | Free Organizational Chart Maker | Miro

An org chart shows how roles and reporting relationships are structured within an organization. It can be on a team level, department level, or company-wide. Depending on what type of org …See details»

Sukienki - Millento

Y&T Trading Co., Limited. Room 1005 10/F Ho King Comn Ctr 2-6 Fa Yuen St Mongkok Kln Hong Kong [email protected] +48 22 103 24 80See details»

linkstock.net © 2022. All rights reserved